6-((4-(Aminomethyl)benzyl)oxy)-7H-purin-2-amine, 95.0%, 250mg

3-(2,4-dimethylphenyl)-1-methyl-1{H}-pyrazole-5-carboxylic acid, 95.0%, 1g

Ethyl 4-chloro-3-fluorobenzoate, 95.0%, 100g

5-Bromo-2-chloro-N-cyclopentylpyrimidin-4-amine, 95.0%, 25g

Ethylene Glycol Diacetate>97.0%(GC)500mL

4-bromo-1-(methanesulfonylmethyl)-1H-pyrazole, 97.0%, 1g

Bis({[(2,2-dimethylpropyl)carbamothioyl]sulfanyl})nickel, 1g

2-Chloroethyl4-nitrophenylether, 95.0%, 5g

Distillation apparatus Micro, 1 Piece

tert-Butyl 2-(2-chloroacetyl)pyrrolidine-1-carboxylate, 95.0%, 5g

GC capillary column ROTI®Cap-1, 25 m, 0.25 mm, 0.25 µm, 1 Piece(s)

6-methyl-2-piperazin-1-yl-1,3-benzothiazole, 95.0%, 500mg

5-amino-2-fluoro-N-methylbenzamide, 95.0%, 5g